US 10800754
Heterocyclic amide compound
granted A61PA61P35/00A61P43/00
Quick answer
US patent 10800754 (Heterocyclic amide compound) held by Takeda Pharmaceutical Company Limited expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P35/00, A61P43/00